A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582237805084672 |
|---|---|
| author | Ji‐Yong Sung Jae‐Ho Cheong Kihye Shin Eui Tae Kim |
| author_facet | Ji‐Yong Sung Jae‐Ho Cheong Kihye Shin Eui Tae Kim |
| author_sort | Ji‐Yong Sung |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7058e2d2991847128300a87cbcc596fc |
| institution | Kabale University |
| issn | 2001-1326 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj-art-7058e2d2991847128300a87cbcc596fc2025-01-30T03:56:55ZengWileyClinical and Translational Medicine2001-13262024-12-011412n/an/a10.1002/ctm2.70079A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancerJi‐Yong Sung0Jae‐Ho Cheong1Kihye Shin2Eui Tae Kim3Center for Genome Engineering, Institute for Basic Science (IBS) Yuseong‐gu Daejeon Republic of KoreaDepartment of Surgery Yonsei University College of Medicine Seoul Republic of KoreaDepartment of Microbiology and Immunology Jeju National University College of Medicine Jeju Republic of KoreaDepartment of Microbiology and Immunology Jeju National University College of Medicine Jeju Republic of Koreahttps://doi.org/10.1002/ctm2.70079 |
| spellingShingle | Ji‐Yong Sung Jae‐Ho Cheong Kihye Shin Eui Tae Kim A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer Clinical and Translational Medicine |
| title | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer |
| title_full | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer |
| title_fullStr | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer |
| title_full_unstemmed | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer |
| title_short | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer |
| title_sort | subtype of cancer associated fibroblast expressing syndecan 2 sdc2 predicts survival and immune checkpoint inhibitor response in gastric cancer |
| url | https://doi.org/10.1002/ctm2.70079 |
| work_keys_str_mv | AT jiyongsung asubtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT jaehocheong asubtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT kihyeshin asubtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT euitaekim asubtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT jiyongsung subtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT jaehocheong subtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT kihyeshin subtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer AT euitaekim subtypeofcancerassociatedfibroblastexpressingsyndecan2sdc2predictssurvivalandimmunecheckpointinhibitorresponseingastriccancer |